The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src

作者: Stefania Gonfloni , John C Williams , Katarina Hattula , Albert Weijland , Rik K Wierenga

DOI: 10.1093/EMBOJ/16.24.7261

关键词: LinkerTyrosine kinaseProto-oncogene tyrosine-protein kinase SrcBiologyPhosphorylationBiophysicsSH2 domainProtein structureSH3 domainBiochemistryBinding site

摘要: The crystal structures of the regulated Src and Hck tyrosine kinases show intramolecular interactions between phosphorylated tail SH2 domain as well SH3 domain, SH2-catalytic linker (SH2-CD linker) catalytic domain. relative contribution these to regulation activity is poorly understood. Mutational analysis Lck revealed that interaction SH2-CD with crucial for regulation. Moreover, three sites one at beginning (Trp260) two back small lobe, opposite cleft (beta2/beta3 loop; alphaC/beta4 loop), impinge on activity. Other activating mutations map front in loop preceding alphaC-helix (beta3/alphaC loop). mutants are deregulated mammalian cells but transform fibroblasts weakly, suggesting may bind cellular components. Interpretation our results basis structure favours a model which correctly positioned exerts an inhibitory function catalysis family members by facilitating displacement alphaC-helix. This study provide template generation versions other protein kinases.

参考文章(47)
G. Gish, L. C. Cantley, Zhou Songyang, T. Pawson, A. P. Laudano, Xingquan Liu, S. R. Brodeur, Regulation of c-Src tyrosine kinase activity by the Src SH2 domain. Oncogene. ,vol. 8, pp. 1119- 1126 ,(1993)
Harold Varmus, Robert A. Weinberg, Genes and the Biology of Cancer ,(1992)
M. Okada, B.W. Howell, M.A. Broome, J.A. Cooper, Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine. Journal of Biological Chemistry. ,vol. 268, pp. 18070- 18075 ,(1993) , 10.1016/S0021-9258(17)46812-8
G. Superti-Furga, S. Fumagalli, M. Koegl, S.A. Courtneidge, G. Draetta, Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. The EMBO Journal. ,vol. 12, pp. 2625- 2634 ,(1993) , 10.1002/J.1460-2075.1993.TB05923.X
D Martin-Zanca, R Oskam, G Mitra, T Copeland, M Barbacid, Molecular and biochemical characterization of the human trk proto-oncogene. Molecular and Cellular Biology. ,vol. 9, pp. 24- 33 ,(1989) , 10.1128/MCB.9.1.24
C Seidel-Dugan, B E Meyer, S M Thomas, J S Brugge, Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src. Molecular and Cellular Biology. ,vol. 12, pp. 1835- 1845 ,(1992) , 10.1128/MCB.12.4.1835
Richard Jove, Hidesaburo Hanafusa, Cell transformation by the viral src oncogene. Annual Review of Cell Biology. ,vol. 3, pp. 31- 56 ,(1987) , 10.1146/ANNUREV.CB.03.110187.000335
Philip D. Jeffrey, Alicia A. Russo, Kornelia Polyak, Emma Gibbs, Jerard Hurwitz, Joan Massagué, Nikola P. Pavletich, Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex Nature. ,vol. 376, pp. 313- 320 ,(1995) , 10.1038/376313A0
Robert M. Kypta, Yves Goldberg, Emin T. Ulug, Sara A. Courtneidge, Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell. ,vol. 62, pp. 481- 492 ,(1990) , 10.1016/0092-8674(90)90013-5